NorthWest Biotherapeutics Inc (NWBO)

[austinmediainc]

I ask this because if both get approved this year or next they will probably compete with each other in off label use in other cancers.

Can a trial finish if it hasn't even fully enrolled? Last I checked we were still in a screening hold.....but the good news is the hold has only been going on for a year since they told us they thought it would be cleared up "shortly" and only 5 years enrolling......NWBO is miles and miles and miles behind ARGS.

PS ARGS tabled the move towards automation and laid off in an effort to not dilute shareholders and have enough funds to complete their Phase III. They have hit every timeline they laid out in regards to enrollment completion, first, second and third interim looks. They understand how important finishing the trial is. If they succeed then they will have all the money they need through non-dilutive means to fast track automation. ARGS also has over 100 employees compared to the 12 of NWBO and manage to operate at less.